Nitta Gelatin India Ltd

Nitta Gelatin India Ltd

₹ 949 0.03%
21 Feb - close price
About

Nitta Gelatin India Ltd is primarily engaged in the manufacture and sale of ossein, gelatin and collagen peptide.[1]

Key Points

Product Portfolio
The company's product portfolio includes wellnex collagen peptides, gelatin, Di calcium phosphate, chitosan, and a few consumer products. [1] The products are used for pharmaceutical, agricultural, industrial, and food applications. [2]

  • Market Cap 862 Cr.
  • Current Price 949
  • High / Low 1,184 / 633
  • Stock P/E 10.2
  • Book Value 341
  • Dividend Yield 0.79 %
  • ROCE 33.1 %
  • ROE 29.2 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 72.7% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
103 105 106 119 139 142 134 146 140 146 128 140 134
88 98 98 108 117 119 113 119 102 119 90 108 102
Operating Profit 14 7 8 11 22 22 21 27 38 27 39 31 32
OPM % 14% 7% 8% 10% 16% 16% 16% 19% 27% 18% 30% 22% 24%
0 1 1 1 1 1 1 0 3 0 3 3 0
Interest 1 1 1 1 1 1 1 2 1 0 0 0 0
Depreciation 4 4 4 4 4 4 3 4 4 4 4 4 4
Profit before tax 9 3 5 8 18 18 18 22 36 23 38 30 29
Tax % 29% 31% 26% 35% 28% 29% 28% 29% 21% 27% 25% 27% 28%
7 2 4 5 13 13 13 15 29 17 28 22 21
EPS in Rs 7.03 2.40 3.71 5.19 13.93 13.44 13.48 16.11 30.02 17.82 30.32 23.45 21.90
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
244 303 287 354 357 356 342 303 342 396 506 565 548
223 260 271 330 321 320 313 273 306 351 442 452 419
Operating Profit 21 43 16 24 36 36 29 30 36 45 64 114 129
OPM % 9% 14% 5% 7% 10% 10% 8% 10% 10% 11% 13% 20% 24%
1 2 0 2 2 9 5 1 2 1 5 4 6
Interest 6 9 8 10 8 7 7 9 8 6 5 4 1
Depreciation 10 16 17 14 13 14 15 15 16 16 14 14 15
Profit before tax 6 20 -9 1 18 24 12 7 13 25 49 99 120
Tax % 24% 55% 23% 358% 53% 49% 61% 33% 8% 29% 29% 25%
5 11 -7 -4 9 12 5 5 12 18 35 74 87
EPS in Rs 4.19 9.59 -6.71 -1.56 11.82 15.61 4.90 3.82 12.38 19.15 36.26 77.44 93.49
Dividend Payout % 72% 31% 0% -64% 21% 16% 51% 39% 20% 16% 11% 10%
Compounded Sales Growth
10 Years: 6%
5 Years: 11%
3 Years: 18%
TTM: -2%
Compounded Profit Growth
10 Years: 20%
5 Years: 73%
3 Years: 82%
TTM: 32%
Stock Price CAGR
10 Years: 29%
5 Years: 51%
3 Years: 77%
1 Year: 39%
Return on Equity
10 Years: 10%
5 Years: 15%
3 Years: 20%
Last Year: 29%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 8 8 9 9 9 9 9 9 9 9 9 9 9
Reserves 96 105 100 99 105 124 139 141 144 164 192 259 301
Preference Capital 0 0 0 0 16 0 0 0 0 0 4 4
60 57 68 66 76 109 104 108 84 80 82 35 21
41 52 49 49 65 59 54 55 57 53 62 64 65
Total Liabilities 205 222 226 223 256 301 306 313 294 306 345 367 396
122 117 125 118 120 110 113 130 121 113 107 114 114
CWIP 7 9 9 9 9 13 10 4 4 2 7 7 8
Investments 1 1 1 1 1 1 1 1 1 1 1 1 1
75 96 92 96 127 177 182 179 169 191 230 246 272
Total Assets 205 222 226 223 256 301 306 313 294 306 345 367 396

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
20 17 24 20 20 11 27 22 40 19 17 101
-20 -13 -24 -8 -14 -3 -7 -14 -10 -7 -14 -18
0 -3 0 -12 18 -5 -20 -7 -33 -12 -2 -55
Net Cash Flow 0 1 -1 0 25 3 -0 1 -3 -0 1 28

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 26 31 28 23 21 54 66 76 37 58 64 57
Inventory Days 121 140 131 100 114 144 153 191 205 161 136 126
Days Payable 62 58 72 51 42 48 53 59 49 43 28 39
Cash Conversion Cycle 84 113 87 72 93 150 165 209 193 176 172 144
Working Capital Days 55 66 62 54 58 97 94 108 78 107 113 90
ROCE % 8% 17% -0% 6% 13% 14% 7% 6% 9% 12% 20% 33%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
74.48% 74.48% 74.48% 74.48% 74.48% 74.48% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49%
0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.26% 0.26% 0.12% 0.12%
25.40% 25.40% 25.40% 25.40% 25.40% 25.40% 25.41% 25.41% 25.26% 25.26% 25.41% 25.40%
No. of Shareholders 5,8986,0146,5726,3576,3756,3997,5938,6508,3328,46610,18311,028

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents